Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare and Social Assistance

>>

Europe Pharmacovigilance and Drug Safety Software Market


Europe Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Country: Trend Forecast and Growth Opportunity

Report code: SDMRHE1641560 | Industry: Healthcare and Social Assistance | Published On: 44773


Europe pharmacovigilance and drug safety software market was valued at $61.1 million in 2021 and will grow by 7.4% annually over 2021-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions.
Highlighted with 33 tables and 60 figures, this 119-page report “Europe Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe pharmacovigilance and drug safety software market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe pharmacovigilance and drug safety software market in every aspect of the classification from perspectives of Functionality, Clinical Phase, Method, Delivery Mode, Indication, End User, and Country.

Based on Functionality, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Adverse Event Reporting Software
• Drug Safety Audits Software
• Issue Tracking Software
• Fully Integrated Software

Based on Clinical Phase, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV

By Method, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

By Delivery Mode, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• On-premise Delivery
• On-demand Delivery

By Indication, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Oncology
• Respiratory Disorders
• Cardiology
• Neurology
• Immunology
• Pain Management
• Other Indications

By End Users, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Business Process Outsourcing Firms (BPOs)
• Other End Users

Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Netherlands
• Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Functionality, Delivery Mode and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Ab Cube
Accenture PLC
ArisEurope LLC
Cognizant Technology Solutions Corporation
Ennov Solutions Inc.
Extedo GmbH
Honeywell International Inc. (Sparta Systems Inc.)
IQVIA Inc.
Max Application
Oracle Corporation
Sarjen Systems Pvt. Ltd.
United BioSource LLC
Veeva Systems Inc.
Wipro Limited
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1  Introduction 8
1.1  Industry  Definition  and  Research  Scope 8
1.1.1  Industry  Definition 8
1.1.2  Research  Scope 9
1.2  Research  Methodology 12
1.2.1  Overview  of  Market  Research  Methodology 12
1.2.2  Market  Assumption 13
1.2.3  Secondary  Data 13
1.2.4  Primary  Data 13
1.2.5  Data  Filtration  and  Model  Design 14
1.2.6  Market  Size/Share  Estimation 15
1.2.7  Research  Limitations 16
1.3  Executive  Summary 17
2  Market  Overview  and  Dynamics 20
2.1  Market  Size  and  Forecast 20
2.1.1  Impact  of  COVID-19  on  World  Economy 21
2.1.2  Impact  of  COVID-19  on  the  Market 25
2.2  Major  Growth  Drivers 27
2.3  Market  Restraints  and  Challenges 32
2.4  Emerging  Opportunities  and  Market  Trends 35
2.5  Porter’s  Fiver  Forces  Analysis 39
3  Segmentation  of  Europe  Market  by  Functionality 43
3.1  Market  Overview  by  Functionality 43
3.2  Adverse  Event  Reporting  Software 45
3.3  Drug  Safety  Audits  Software 46
3.4  Issue  Tracking  Software 47
3.5  Fully  Integrated  Software 48
4  Segmentation  of  Europe  Market  by  Clinical  Phase 49
4.1  Market  Overview  by  Clinical  Phase 49
4.2  Pre-clinical 51
4.3  Phase  I 52
4.4  Phase  II 53
4.5  Phase  III 54
4.6  Phase  IV 55
5  Segmentation  of  Europe  Market  by  Method 56
5.1  Market  Overview  by  Method 56
5.2  Spontaneous  Reporting 58
5.3  Intensified  ADR  Reporting 59
5.4  Targeted  Spontaneous  Reporting 60
5.5  Cohort  Event  Monitoring 61
5.6  EHR  Mining 62
6  Segmentation  of  Europe  Market  by  Delivery  Mode 63
6.1  Market  Overview  by  Delivery  Mode 63
6.2  On-premise  Delivery 65
6.3  On-demand  Delivery 66
7  Segmentation  of  Europe  Market  by  Indication 67
7.1  Market  Overview  by  Indication 67
7.2  Oncology 69
7.3  Respiratory  Disorders 70
7.4  Cardiology 71
7.5  Neurology 72
7.6  Immunology 73
7.7  Pain  Management 74
7.8  Other  Indications 75
8  Segmentation  of  Europe  Market  by  End  User 76
8.1  Market  Overview  by  End  User 76
8.2  Pharmaceutical  and  Biotechnology  Companies 78
8.3  Contract  Research  Organizations  (CROs) 79
8.4  Business  Process  Outsourcing  Firms  (BPOs) 80
8.5  Other  End  Users 81
9  European  Market  2021-2031  by  Country 82
9.1  Overview  of  European  Market 82
9.2  Germany 85
9.3  U.K. 88
9.4  France 90
9.5  Spain 92
9.6  Italy 94
9.7  Netherlands 96
9.8  Rest  of  European  Market 98
10  Competitive  Landscape 100
10.1  Overview  of  Key  Vendors 100
10.2  New  Product  Launch,  Partnership,  Investment,  and  M&A 103
10.3  Company  Profiles 104
Ab  Cube 104
Accenture  PLC 106
ArisEurope  LLC 107
Cognizant  Technology  Solutions  Corporation 108
Ennov  Solutions  Inc. 109
Extedo  GmbH 110
Honeywell  International  Inc.  (Sparta  Systems  Inc.) 111
IQVIA  Inc. 112
Max  Application 113
Oracle  Corporation 114
Sarjen  Systems  Pvt.  Ltd. 115
United  BioSource  LLC 116
Veeva  Systems  Inc. 117
Wipro  Limited 118
RELATED  REPORTS 119
List of Tables:

Table 1. Snapshot of Europe Pharmacovigilance and Drug Safety Software Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. Main Product Trends and Market Opportunities in Europe Pharmacovigilance and Drug Safety Software Market 35
Table 5. Europe Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 43
Table 6. Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, $ mn 49
Table 7. Europe Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, $ mn 56
Table 8. Europe Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 63
Table 9. Europe Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, $ mn 67
Table 10. Europe Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 76
Table 11. Europe Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 84
Table 12. Germany Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 86
Table 13. Germany Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 86
Table 14. Germany Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 86
Table 15. U.K. Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 89
Table 16. U.K. Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 89
Table 17. U.K. Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 89
Table 18. France Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 91
Table 19. France Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 91
Table 20. France Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 91
Table 21. Spain Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 93
Table 22. Spain Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 93
Table 23. Spain Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 93
Table 24. Italy Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 95
Table 25. Italy Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 95
Table 26. Italy Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 95
Table 27. Netherlands Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 97
Table 28. Netherlands Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 97
Table 29. Netherlands Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 97
Table 30. Pharmacovigilance and Drug Safety Software Market in Rest of Europe by Country, 2021-2031, $ mn 99
Table 31. Ab Cube: Company Snapshot 104
Table 32. Ab Cube: Business Segmentation 105
Table 33. Ab Cube: Product Portfolio 105
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT